Menu Close

Research participation associated with greater adherence to medications for dementia, fewer racial disparities

New research conducted by investigators from the Alzheimer’s Disease Research Center at Mount Sinai has revealed that while older participants with Alzheimer’s dementia who were followed in research studies were more likely to receive approved medications for their dementia than those not enrolled in research studies, Black and Latino participants had lower rates of medication uptake and persistent use than White participants. These results, published February 25 in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, point to substantial racial/ethnic treatment disparities that remain in controlled settings of longitudinal research where participants have access to dementia experts, suggesting wider disparities likely exist in the broader community.